Jobs

🚨🚨UPDATED EVERY WEEK  🚨🚨

19 th of March:
1) Lund University via MyNetwork - Project assistant in computational genome analysis

2) FAPESP, SAO PAULO RESEARCH FOUNDATION - Post-Doctoral Fellowship in Medicine

3) ResearchJobs.cz - Postdoctoral Researcher in Structural Virology

13 th of March:
1) Research Scientist - University of Texas at Austin, United States

2) Postdoctoral Associate, Microbiology and Immunology - SUNY University at Buffalo, United States

3) University of Thessaly - Short Term PhD fellowship on Soil Microbial Ecology

4) University of Thessaly - One Short Term Postdoc Position in Environmental Risk Assessment

5) ABG - Association Bernard Gregory - Role of anti-phage antibodies in pulmonary phage therapy - Sorbonne Université SIS

06 th of March:
1) Phd Offer, TOWARDS ARTIFICIAL BACTERIOPHAGES, ABG - Association Bernard Gregory, École normale supérieure de Lyon

2)  Postdoctoral Fellow - Microbiology and Immunology-Otago University - NZ

3)  Research Associate in Structural Biology - Imperial College London, United Kingdom

4)  Characterisation of the role of prophages in the epithelial pathogenesis of AIEC - Association Bernard Gregory, University of Lille

5)  USDA-ARS Vaccine and Bacteriophage Research for Aquatic Health - Zintellect, United States

6)  Research Associate in Bacteriophage Biomanufacturing - Loughborough University - School of Aeronautical, Automotive, Chemical and Materials Engineering

7)  Associação do Instituto Superior Técnico para a Investigação e Desenvolvimento _IST-ID - Research Studentships (for students of a course that does not award an academic degree) - (BL39/2026-IST-ID)

28 th of February:
1)  Malopolska Centre of Biotechnology - Assistant Professor 

2)  Microbiology - University of Glasgow, United Kingdom

3)  Research Technician II - Biochemistry - University of Washington, United States

4)  Dissecting the molecular events during Jumbophage antibacterial virus infection - School of Clinical Dentistry - University of Sheffield 

5)  Universidade de São Paulo - Chemistry Institute- Post-Doctoral Fellowship in Bacteriophage Genomics


22 sd of February:

1)  Research Fellow in Environmental/Molecular Microbiology - 0.8 FTE (Internal Only) - University of Brighton, United Kingdom
2)  BCAS - Associate or Full Professor of Microbiology in Biological Sciences - 527688- The University of Alabama, United States

3)  Bacteriophage engineering as a therapeutic strategy to target antibiotic resistant enterococci
University of Sheffield, United Kingdom

4)  Research Fellow (Genome Editing - Directed Evolution) - National University of Singapore, Singapore

5)  Post Doctoral Associate - Biology - University of Miami, United States

6)  Associate in Research - Duke University, United States

7)  In Residence Faculty Position | UCSF Dept of Bioengineering and Therapeutics Sciences / Gladstone - Nature Careers, United States

8)  University of Pisa - 3 years PhD position - MSCA project METAMIC 3 Project

16 th of February:
1)  Postdoctoral Research Associate - University of Sydney, Australia

2) Postdoctoral Research Associate - Biochemistry - University of Washington, United States

3) Postdoctoral Research Associate Senior - University of Texas at Tyler, United States

4) Research Lab Specialist Associate - University of Michigan, United States

5) Senior Scientist – Display Technologies (Antibody Discovery) - Cancer Research UK - Research & Innovation

6) Centro de Engenharia Biológica da Universidade do Minho - Research Fellowship - CENTRE OF BIOLOGICAL ENGINEERING: CEB-BI-07-2026

7) Lund University via MyNetwork - Bioinformatician in Microbial Gene Context Analysis

8) United Kingdom - Times Higher Education -Research Assistant in Synthetic Biology

6 th of February:
1) Postdoctoral position – Synthetic Biology / Bacterial Immunity - Institut Pasteur, France

2) ABG - Association Bernard Gregory - Bacterial DNA methylation in conflict, adaptation, and intervention: from metagenomic analysis to pharmacological inhibition

3) Dissecting the molecular events during Jumbophage antibacterial virus infection - University of Sheffield, United Kingdom

4) PhD scholarship in Antibody Dependent Enhancement of Toxicity for Snake Venom Metalloproteases - DTU Bioengineering - Technical University of Denmark, Denmark

5) Academic Positions - Research Scientist, Immunotechnology - Finland

29 th of January:
1) Italian Ministry of Education, University and Research - The isolation and chemical-physical and biological characterisation of human anti-CNA antistaphylococcal antibodies for use in biomedicine

2)  Postdoctoral Research Associate - University of York, United Kingdom

3) Postdoctoral Research Fellow - Harvard University, United States

4) Research Associate, Microbiology/Molecular Biology [LKCMedicine] - Nanyang Technological University, Singapore

5) Postdoctoral Research Associate - University of Sydney, Australia

6) Centro de Engenharia Biológica da Universidade do Minho - PhD Research Fellowship - CENTRE OF BIOLOGICAL ENGINEERING: CEB-BI-14-2025 - New microfluidic tools for rapid phage therapy testing and manufacturing

7) Helmholtz-Zentrum für Infektionsforschung GmbH - Helmholtz Junior Research Group Leaders (f/m/d) (with tenure option)

8) PhD fellowship in the discovery of small antimicrobial phage proteins- Frederiksberg, Danmark (Denmark)

Comments

Post a Comment

Most Consulted Articles

History Part 12 : Post-War Stagnation and Phage Therapy’s Marginalization in the West (1945–1980s)

Image
Post-War Stagnation and Phage Therapy’s Marginalization in the West (1945–1980s) The period following World War II marked a decisive turning point in the trajectory of phage therapy in Western medicine. Despite the promising results bacteriophages had demonstrated prior to the war as potential antibacterial agents, the decades after 1945 saw a dramatic decline in interest, funding, and scientific engagement with phage therapy in the United States and much of Western Europe. This marginalization can be attributed to a confluence of scientific, sociopolitical, and economic factors that reshaped the landscape of infectious disease treatment and research. Artistic View One of the key contributors to this decline was the overwhelming optimism surrounding the newly discovered class of antibiotics. The post-war pharmaceutical revolution brought forward a series of broad-spectrum antibiotics such as streptomycin, tetracycline, and chloramphenicol, which were viewed as miracle drugs capable o...
Read more

The Phage Therapy in the spotlight !

Image
Bacteriophages: Ancient Predators and the Next Frontier in Medicine In the animated documentary The Deadliest Being on Planet Earth , the Kurzgesagt team delves into the world of bacteriophages—viruses that prey exclusively on bacteria. With vibrant visuals and precise narration, the video introduces viewers to an invisible ecosystem where microscopic hunters orchestrate life-and-death dramas that shape the biosphere. These entities, though virtually unknown to the general public, may soon become central to the future of medicine. At the heart of the video lies a paradox: bacteriophages (or "phages") are among the most abundant biological entities on Earth—outnumbering all other organisms combined—yet their therapeutic potential has been largely sidelined in the antibiotic era. The video outlines the historical trajectory of phage research, spotlighting Félix d’Hérelle’s early 20th-century work and the rise of phage therapy, only to show how it was later eclipsed by the dis...
Read more

Groundbreaking achievement : Phagos raises €25m to end bacterial disease

Image
 Phagos raises €25m to end bacterial disease  The company holds the first authorization to market personalized veterinary phage-based treatments on EU soil  ● Founded in 2021, Phagos is ushering in a new era in the fight against bacterial disease with bacteriophages, a powerful alternative to antibiotics. Thanks to an unprecedented regulatory breakthrough and a discovery platform combining microbiology and AI, Phagos offers the first phage-based drugs for veterinary use, a market worth tens of billions of dollars. The company plans to expand further as phage therapy becomes accepted in human health.                              ● The funding round was co-led by CapAgro, Hoxton Ventures, CapHorn, and Demeter alongside Acurio Ventures, Citizen Capital, Entrepreneur First, Founders Capital, and Station F.  ● Objectives: deploy veterinary treatments in the field, develop the next generation of pat...
Read more